InsidersTradesSigma
Browse the full record of transactions filed by Per Wold-Olsen, Président du Conseil. Director active across 6 companies, notably Senzime AB. In total, 4 disclosures have been published. The latest transaction was filed on 17 March 2026 — Purchase. Regulator: FIN-FSA. The full history is free.
4 of 4 declarations
Per Wold-Olsen is the chairman of the board of Senzime AB. He oversees the board's activities and plays a key role in the strategic direction of the company. Senzime AB specializes in developing medical solutions. Per Wold-Olsen contributes to corporate governance and strategic decision-making, ensuring the success and growth of the organization.